These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19433009)

  • 1. From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour.
    Nathan PJ; Bullmore ET
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):995-1008. PubMed ID: 19433009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating.
    Giuliano C; Robbins TW; Nathan PJ; Bullmore ET; Everitt BJ
    Neuropsychopharmacology; 2012 Nov; 37(12):2643-52. PubMed ID: 22805601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic prevention of mu-opioid receptor (MOR) G-protein coupling in the pontine parabrachial nucleus persistently decreases consumption of standard but not palatable food.
    Ward HG; Simansky KJ
    Psychopharmacology (Berl); 2006 Sep; 187(4):435-46. PubMed ID: 16847679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder.
    Heal DJ; Hallam M; Prow M; Gosden J; Cheetham S; Choi YK; Tarazi F; Hutson P
    J Psychopharmacol; 2017 Jun; 31(6):770-783. PubMed ID: 28376679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reward systems and food intake: role of opioids.
    Gosnell BA; Levine AS
    Int J Obes (Lond); 2009 Jun; 33 Suppl 2():S54-8. PubMed ID: 19528981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of mu opioid receptors reduces palatable solution intake in a mouse model of binge eating.
    Awad G; Roeckel LA; Massotte D; Olmstead MC; Befort K
    Behav Pharmacol; 2020 Apr; 31(2&3):249-255. PubMed ID: 31503073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous opioid modulation of food intake and body weight: Implications for opioid influences upon motivation and addiction.
    Bodnar RJ
    Peptides; 2019 Jun; 116():42-62. PubMed ID: 31047940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binge-Type Eating in Rats is Facilitated by Neuromedin U Receptor 2 in the Nucleus Accumbens and Ventral Tegmental Area.
    Smith AE; Kasper JM; ; Anastasio NC; Hommel JD
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30717427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emotional Eating, Binge Eating and Animal Models of Binge-Type Eating Disorders.
    Turton R; Chami R; Treasure J
    Curr Obes Rep; 2017 Jun; 6(2):217-228. PubMed ID: 28434108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated binge-like eating episodes in female rats alter adenosine A
    Mercante F; Micioni Di Bonaventura E; Pucci M; Botticelli L; Cifani C; D'Addario C; Micioni Di Bonaventura MV
    Int J Eat Disord; 2024 Jul; 57(7):1433-1446. PubMed ID: 38650547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The opioid system and food intake: homeostatic and hedonic mechanisms.
    Nogueiras R; Romero-Picó A; Vazquez MJ; Novelle MG; López M; Diéguez C
    Obes Facts; 2012; 5(2):196-207. PubMed ID: 22647302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid system in the medial prefrontal cortex mediates binge-like eating.
    Blasio A; Steardo L; Sabino V; Cottone P
    Addict Biol; 2014 Jul; 19(4):652-62. PubMed ID: 23346966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens.
    Selleck RA; Baldo BA
    Psychopharmacology (Berl); 2017 May; 234(9-10):1439-1449. PubMed ID: 28054099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.
    Mason AE; Lustig RH; Brown RR; Acree M; Bacchetti P; Moran PJ; Dallman M; Laraia B; Adler N; Hecht FM; Daubenmier J; Epel ES
    Appetite; 2015 Aug; 91():311-320. PubMed ID: 25931433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects.
    Ziauddeen H; Chamberlain SR; Nathan PJ; Koch A; Maltby K; Bush M; Tao WX; Napolitano A; Skeggs AL; Brooke AC; Cheke L; Clayton NS; Sadaf Farooqi I; O'Rahilly S; Waterworth D; Song K; Hosking L; Richards DB; Fletcher PC; Bullmore ET
    Mol Psychiatry; 2013 Dec; 18(12):1287-93. PubMed ID: 23147384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese people.
    Cambridge VC; Ziauddeen H; Nathan PJ; Subramaniam N; Dodds C; Chamberlain SR; Koch A; Maltby K; Skeggs AL; Napolitano A; Farooqi IS; Bullmore ET; Fletcher PC
    Biol Psychiatry; 2013 May; 73(9):887-94. PubMed ID: 23245760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine for "wanting" and opioids for "liking": a comparison of obese adults with and without binge eating.
    Davis CA; Levitan RD; Reid C; Carter JC; Kaplan AS; Patte KA; King N; Curtis C; Kennedy JL
    Obesity (Silver Spring); 2009 Jun; 17(6):1220-5. PubMed ID: 19282821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food.
    Tallett AJ; Blundell JE; Rodgers RJ
    Behav Brain Res; 2008 Mar; 187(2):417-27. PubMed ID: 18022706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioidergic consequences of dietary-induced binge eating.
    Bello NT; Patinkin ZW; Moran TH
    Physiol Behav; 2011 Jul; 104(1):98-104. PubMed ID: 21539852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist.
    Ignar DM; Goetz AS; Noble KN; Carballo LH; Stroup AE; Fisher JC; Boucheron JA; Brainard TA; Larkin AL; Epperly AH; Shearer TW; Sorensen SD; Speake JD; Hommel JD
    J Pharmacol Exp Ther; 2011 Oct; 339(1):24-34. PubMed ID: 21712426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.